Response to the Letter to the Editor: Prospective comparison of 18F-PSMA-1007 PET/CT, whole-body MRI and CT in primary nodal staging of unfavourable intermediate- and high-risk prostate cancer
Sign Up to like & getrecommendations! Published in 2021 at "European Journal of Nuclear Medicine and Molecular Imaging"
DOI: 10.1007/s00259-021-05428-7
Abstract: We thank Dr. Campaña and Dr. Bernal for their interest in our recent study about the prospective comparison of 18F-PSMA-1007 PET/CT, whole-body MRI with diffusionweighted imaging (DWI) and contrast-enhanced CT in primary nodal staging of… read more here.
Keywords: psma; 18f psma; prostate cancer; psma 1007 ... See more keywords
Preclinical Evaluation of a Companion Diagnostic Radiopharmaceutical, [18F]PSMA-1007, in a Subcutaneous Prostate Cancer Xenograft Mouse Model
Sign Up to like & getrecommendations! Published in 2022 at "Molecular Pharmaceutics"
DOI: 10.1021/acs.molpharmaceut.2c00788
Abstract: Several radiolabeled prostate-specific membrane antigen (PSMA)-targeted agents have been developed for detecting prostate cancer, using positron emission tomography imaging and targeted radionuclide therapy. Among them, [18F]PSMA-1007 has several advantages, including a comparatively long half-life, delayed… read more here.
Keywords: prostate cancer; psma; psma 1007; 18f psma ... See more keywords
Rib Fractures Mimicking Bone Metastases in 18F-PSMA-1007 PET/CT for Prostate Cancer.
Sign Up to like & getrecommendations! Published in 2019 at "Clinical Nuclear Medicine"
DOI: 10.1097/rlu.0000000000002354
Abstract: Prostate-specific membrane antigen (PSMA) is a membrane glycoprotein that is overexpressed in prostate cancer cells. It is also expressed in other normal tissues and several other malignant and benign diseases. We present a case of… read more here.
Keywords: psma 1007; prostate cancer; psma; 1007 pet ... See more keywords
A Comparison of 18F-PSMA-1007 and 64Cu-PSMA in 2 Patients With Metastatic Prostate Cancer.
Sign Up to like & getrecommendations! Published in 2021 at "Clinical nuclear medicine"
DOI: 10.1097/rlu.0000000000003758
Abstract: ABSTRACT 18F-prostate-specific membrane antigen (PSMA) 1007 is one of the most promising radiotracers for PET imaging in prostate cancer, minimal urinary clearance, and higher spatial resolution, which are the most outstanding features. PSMA can also… read more here.
Keywords: psma 1007; psma; metastatic prostate; prostate cancer ... See more keywords
Increased Uptake of 18F-PSMA-1007 in Corpus Luteum Demonstrated by PET/CT.
Sign Up to like & getrecommendations! Published in 2022 at "Clinical nuclear medicine"
DOI: 10.1097/rlu.0000000000004013
Abstract: ABSTRACT Two women were referred for an 18F-PSMA-1007 PET/CT in follow-up of an adenoid cystic tumor of the subglottic region and the bronchus, respectively. Only limited tracer uptake was seen in the region of local… read more here.
Keywords: psma 1007; 18f psma; pet; corpus luteum ... See more keywords
Comparison of Internal Dosimetry of 18F-PSMA-1007 and 68Ga-PSMA-11-HBED-CC
Sign Up to like & getrecommendations! Published in 2022 at "Clinical Nuclear Medicine"
DOI: 10.1097/rlu.0000000000004353
Abstract: Background Prostate cancer (PCa) is the most common cancer in men worldwide. Targeting prostate-specific membrane antigen (PSMA) using radiopharmaceuticals has shown promising results for PCa imaging as well as theranostics. 68Ga-based PSMA imaging is limited… read more here.
Keywords: mgy mbq; psma hbed; 68ga psma; psma ... See more keywords
Comparison of 18F-PSMA-1007 PET/CT With 68Ga-PSMA-11 PET/CT for Initial Staging in Intermediate- and High-Risk Prostate Cancer
Sign Up to like & getrecommendations! Published in 2022 at "Clinical Nuclear Medicine"
DOI: 10.1097/rlu.0000000000004430
Abstract: Purpose This study aimed to compare 18F-PSMA-1007 PET/CT with 68Ga-PSMA-11 PET/CT for initial staging in intermediate- and high-risk prostate cancer (PCa) patients. Methods Forty treatment-naive, biopsy-proven, intermediate- or high-risk PCa patients were prospectively recruited. Each… read more here.
Keywords: pet; 68ga psma; psma; 1007 pet ... See more keywords
Biokinetics and dosimetry of 18F‐PSMA‐1007 in patients with prostate cancer
Sign Up to like & getrecommendations! Published in 2022 at "Clinical Physiology and Functional Imaging"
DOI: 10.1111/cpf.12785
Abstract: Positron emission tomography‐computed tomography (PET‐CT) using prostate‐specific membrane antigen (PSMA) ligands is a method for imaging prostate cancer. A recent tracer, 18F‐PSMA‐1007, offers advantages concerning production and biokinetics compared to the standard tracer (68Ga‐PSMA‐11). Until… read more here.
Keywords: biokinetics dosimetry; prostate cancer; dosimetry 18f; psma 1007 ... See more keywords
Phase III Study of 18F-PSMA-1007 Versus 18F-Fluorocholine PET/CT for Localization of Prostate Cancer Biochemical Recurrence: A Prospective, Randomized, Crossover Multicenter Study
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Nuclear Medicine"
DOI: 10.2967/jnumed.122.264743
Abstract: Visual Abstract The objective of this study was to compare 18F-PSMA-1007 PET/CT and 18F-fluorocholine PET/CT for the localization of prostate cancer (PCa) biochemical recurrence. Methods: This prospective, open-label, randomized, crossover multicenter study included PCa patients… read more here.
Keywords: psma 1007; 18f psma; pet; 18f fluorocholine ... See more keywords
Intra-Individual Comparison of 18F-PSMA-1007 and 18F-FDG PET/CT in the Evaluation of Patients With Prostate Cancer
Sign Up to like & getrecommendations! Published in 2020 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2020.585213
Abstract: Purpose 18F labelled PSMA-1007 presents promising results in detecting prostate cancer (PC), while some pitfalls exists meanwhile. An intra-individual comparison of 18F-FDG and 18F-PSMA-1007 in patients with prostate cancer were aimed to be performed in… read more here.
Keywords: pet; psma 1007; 18f psma; suvmax suvmean ... See more keywords
Evaluation of a radiomics nomogram derived from Fluoride-18 PSMA-1007 PET/CT for risk stratification in newly diagnosed prostate cancer
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.1018833
Abstract: Objective The aim of this study was to evaluate the performance of Fluoride-18 (18F)-PSMA-1007-PET/CT radiomics for the tumor malignancy and clinical risk stratification in primary prostate cancer (PCa). Materials and Methods A total of 161… read more here.
Keywords: psma 1007; pet; risk stratification; 1007 pet ... See more keywords